Home
Mercati
Grafici & Idee
Algo
Notizie
Store
Broker
Scarica
Calendario Economico
Segnali di Trading
Terminale Web
Digita
/
per cercare: @user, $symbol
Cerca
Accedi
Crea un account
Italiano
English
Русский
中文
Español
Português
日本語
Deutsch
한국어
Français
Türkçe
TXG
#1442
10x Genomics, Inc. Class A Common Stock
23.050
0
+15.37%
Settore:
Base:
Valuta di Profitto:
Intervallo Giornaliero
Intervallo Annuale
Variazione giornaliera
+15.37%
Variazione Mensile
+6.71%
Variazione di 6 mesi
+66.79%
Variazione Annuale
+66.79%
Chiusura Precedente
19.980
0
Open
23.050
0
Bid
Ask
Low
23.050
0
High
23.050
0
Volume
221
Mercati
Mercato Azionario Statunitense
Salute
TXG
Open full chart
Financials
Overview
Estratto Conto
Statistics
Dividends
Quarterly
Annual
Value
Q3, 24
Q4, 24
Q1, 25
Q2, 25
Q3, 25
Q4, 25
TTM
Key stats
Total common shares outstanding
121.05 M
122.3 M
123.13 M
124.49 M
126.55 M
127.75 M
—
Valuation ratios
Enterprise value
2.34 B
1.41 B
697.9 M
1.04 B
1.05 B
1.61 B
4.4 B
Price to earnings ratio
-14.66
-9.45
-6.72
-16.54
-18.85
-46.6
-88.71
Price to sales ratio
4.27
2.83
1.69
2.19
2.24
3.17
9.29
Price to cash flow ratio
-209.77
259.56
42.66
28.29
16.45
14.96
102.35
Price to book ratio
0.93
2.44
0.37
0.49
0.48
2.56
3.89
Enterprise value to EBITDA ratio
-14.32
-8.9
-5.07
-15.59
-18.56
-64.94
-104.16
Profitability ratios
Return on assets %
0.04
0.05
0.04
0.04
0.03
-0.05
0.05
Return on equity %
0.05
0.07
0.05
0.04
0.03
-0.07
0.06
Return on invested capital %
34.02
43.2
35.06
25.25
26.74
-35.49
51.56
Gross margin %
70.16
67.24
68.08
72.34
67.32
68.09
275.83
Operating margin %
27.36
30.2
25.39
17.42
21.64
-24.52
39.93
EBITDA margin %
-21.44
-24.9
-20.21
21.94
-14.73
-5.71
-18.71
Net margin %
23.58
29.71
22.18
19.97
18.44
-31.82
28.78
Liquidity ratios
Quick ratio
4.12
4.26
4.68
5.23
4.06
4.09
18.06
Current ratio
4.9
4.97
5.37
5.84
4.48
4.46
20.15
Inventory turnover
—
—
—
—
—
—
—
Asset turnover
0.16
0.18
0.17
0.18
0.15
0.16
0.66
Solvency ratios
Debt to assets ratio
—
—
—
—
—
—
—
Debt to equity ratio
—
—
—
—
—
—
—
Long term debt to total assets ratio
—
—
—
—
—
—
—
Long term debt to total equity ratio
—
—
—
—
—
—
—
Per share metrics
Operating cash flow per share
0.04
-0.06
0.28
0.14
0.34
0.33
1.09
EBIT per share
-0.34
-0.41
-0.32
0.24
-0.26
-0.16
-0.49
EBITDA per share
-0.27
-0.34
-0.26
0.3
-0.17
-0.08
-0.2
Total debt per share
—
—
—
—
—
—
—
Cash per share
3.3
3.27
3.48
3.59
3.84
4.2
15.11
Net current asset value per share
4.92
4.85
4.73
5.27
5.26
5.49
20.74
Tangible book value per share
5.82
5.73
5.6
6.06
5.7
5.85
23.21
Working capital per share
3.91
3.88
3.85
4.36
4.08
4.26
16.55
Book value per share
5.99
5.9
5.77
6.21
6.26
6.38
24.62
10x Genomics Inc
10x Genomics, Inc. is an American biotechnology company that designs and manufactures sequencing technologies for use in scientific research, with a focus on product development for single-cell and spatial omics.
Notizie
Canada stocks higher at close of trade; S&P/TSX Composite up 0.61%
Tempus AI Stock Before Q4 Earnings Release: To Buy or Not to Buy?
Priceline, Carvana, DoorDash and more set to report earnings Wednesday
10x Genomics, Inc. (TXG) Q4 2025 Earnings Call Transcript
Obiettivo di prezzo per le azioni di 10X Genomics alzato a $22 da $20 da Canaccord Genuity
10X Genomics stock price target raised to $22 from $20 at Canaccord Genuity
Applied Materials and Rivian among market cap stock movers on Friday
Compared to Estimates, 10x Genomics (TXG) Q4 Earnings: A Look at Key Metrics
10x Genomics (TXG) Reports Q4 Loss, Beats Revenue Estimates
10X Genomics affronta la prova degli utili con il debutto della nuova strategia di prezzi
10X Genomics faces earnings test as new pricing strategy debuts
Canada stocks higher at close of trade; S&P/TSX Composite up 0.71%